Legislative Proposal, Bill or Resolution, Policies or Program
Pharmaceutical intellectual property proposals that are part of the Comprehensive Economic and Trade Agreement with the European Union.
Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
Acts that propose to amend the Food and Drug Act and amendments to the Food and Drug Regulations related to the regulation of pharmaceuticals, biologic therapies, medical devices and foods.
Legislative Proposal, Bill or Resolution, Regulation
Similar Entry Biologics (SEBs): requiring a Health Canada regulatory framework that support the approval of SEBs
Policies or Program
Common Drug Review (CDR), with respect to health economics assessment and recommendations made on new medicines.
Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement
Regulation
Industry Canada Patented Medicines Notice of Compliance (PMNOC) Regulations, as this relates to regulating intellectual property of prescription drugs
Patented Medicine Prices Review Board (PMPRB) Regulations.
with regard to prices charged by patentees for patented medicines sold in Canada.
Communication Techniques
Written communication
Oral communication
Government Institutions
Aboriginal Affairs and Northern Development Canada
Canadian Institutes of Health Research (CIHR)
Correctional Service of Canada (CSC)
Finance Canada (FIN)
Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
House of Commons
Immigration and Refugee Board (IRB)
Industry Canada
National Defence (DND)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Public Health Agency of Canada (PHAC)
Public Works and Government Services Canada
Royal Canadian Mounted Police (RCMP)
Senate of Canada
Veterans Affairs Canada (VAC)
In-house Corporation Details
Description of activities
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.
Responsible officer name and position during the period of this registration
Felipe Pastrana,
General Manager
Government funding
No government funding was received during the last completed financial year.